MarginsXMarginsX
Home › Markets › Health Care › CNMD

CONMED Corporation (CNMD)

CNMD trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$49.35
-2.45% on the day
Market cap
$1.5B
Small cap
Revenue · 2025
$1.4B
+5.2% on 2024
Net income · 2025
$47.1M
3.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/816956/000081695626000009/0000816956-26-000009-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCNMD on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year1987
SEC CIK0000816956
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.4B
Net income$47.1M
Operating income$102.6M
Net margin3.4%
Operating margin7.5%
Revenue growth+5.2%
Cash$40.8M
Total assets$2.3B
P/E (computed)31.3×
P/S (computed)1.1×

Warning signs

Cash runway
Cash-flow positive
$48.0M cash at September 30, 2026
Share count, 1 year
-3.8%
2025-11-03 to 2026-10-26 · -3.1% over 3 years
Going-concern doubt
No
10-Q filed October 28, 2026
Insider net buying, 12 months
-$161K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-28
Cash and burn$48.0M cash; operating cash flow $44.6M a quarter.Report 2026-09-30
Shares outstanding29,803,323 (2026-10-26); 30,967,954 a year earlier; 30,752,199 three years earlier.Cover page 2026-10-26
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Victor, New York, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $161K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$335.6M$19.8M$49.4M$48.0M$815.9MNeeds four quarters10-Q 2026-10-28
Q2 2026
2026-06-30
$343.5M$23.1MNot filed$37.3M$834.2MNeeds four quarters10-Q 2026-07-29
Q4 2025
2025-12-31
$373.2M$16.7M$46.3M$40.8M$834.9M$1.4B10-K 2026-02-17
Q3 2025
2025-09-30
$337.9M$2.9M$53.7M$38.9M$853.8M$1.3B10-Q 2026-10-28
Q2 2025
2025-06-30
$342.3M$21.4M$29.1M$33.9M$881.8M$1.3B10-Q 2026-07-29
Q1 2025
2025-03-31
$321.3M$6.0M$41.5M$35.5M$892.2M$1.3B10-Q 2025-05-01
Q4 2024
2024-12-31
$345.9M$33.8M$43.3M$24.5M$905.8M$1.3B10-K 2026-02-17
Q3 2024
2024-09-30
$316.7M$49.0M$51.2M$38.5M$940.8M$1.3B10-Q 2025-11-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-02-17
Latest quarterly / interim10-Q2026-10-28
Latest current report8-K2026-10-28
Latest proxyDEFA14A2026-04-07

Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.8%
1 month+11.1%
3 months+1.5%
Year to date+24.6%
1 year+16.9%
From 52-week high-5.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
CBLLCeriBell Inc.$26.42+1.07%$1.0B
INMDInMode Ltd.$13.15-0.90%$755.9M
TMDXTransMedics Group Inc.$92.21+0.91%$3.2B
AXGNAxogen Inc.$55.38-0.98%$3.3B
LIVNLivaNova PLC$92.44+1.23%$5.1B
CVCapsoVision Inc.$6.47+7.30%$346.9M
ELMDElectromed Inc.$23.10-5.02%$188.8M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier